Friedman, Sandor A.; Bienenstock, Harry; Richter, Isaac H.
March 1969
Angiology;Mar1969, Vol. 20 Issue 3, p136
Academic Journal
Two patients with the simultaneous occurrence of malignancy and unexplained generalized arterial disease have been presented. Since extirpation of the tumors and discharge from the hospital, there has been no evidence of progression of the arterial disease or of recurrence of carcinoma in either patient.


Related Articles

  • The North American Control Animal Database: A Resource Based on Standardized Nomenclature and Diagnostic Criteria. Keenan, Charlotte; Hughes-Earle, Angela; Case, Marvin; Stuart, Barry; Lake, Stephen; Mahrt, Charles; Halliwell, William; Westhouse, Richard; Elwell, Michael; Morton, Daniel; Morawietz, Gerd; Rittinghausen, Susanne; Deschl, Ulrich; Mohr, Ulrich // Toxicologic Pathology;Jan/Feb2002, Vol. 30 Issue 1, p75 

    Historical control data have been shown to be valuable in the interpretation and evaluation of results from rodent carcinogenicity studies. Standardization of terminology and histopathology procedures is a prerequisite for meaningful comparison of control data across studies and analysis of...

  • Cancer Risk Following Growth Hormone Use in Childhood. Ogilvy-Stuart, Amanda L.; Gleeson, Helena // Drug Safety;2004, Vol. 27 Issue 6, p369 

    The therapeutic use of growth hormone (GH) has caused concern, as it is anabolic and mitogenic, and its effector hormone, insulin-like growth factor (IGF)-I is anti-apoptotic. As both hormones can cause proliferation of normal and malignant cells, the possibility that GH therapy may induce...

  • Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy. Li, Shenduo; Kennedy, Margaret; Payne, Sturgis; Kennedy, Kelly; Seewaldt, Victoria L.; Pizzo, Salvatore V.; Bachelder, Robin E. // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Although many tumors regress in response to neoadjuvant chemotherapy, residual tumor cells are detected in most cancer patients post-treatment. These residual tumor cells are thought to remain dormant for years before resuming growth, resulting in tumor recurrence. Considering that recurrent...

  • Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Gatenby, R A; Smallbone, K; Maini, P K; Rose, F; Averill, J; Nagle, R B; Worrall, L; Gillies, R J // British Journal of Cancer;9/3/2007, Vol. 97 Issue 5, p646 

    Conceptual models of carcinogenesis typically consist of an evolutionary sequence of heritable changes in genes controlling proliferation, apoptosis, and senescence. We propose that these steps are necessary but not sufficient to produce invasive breast cancer because intraductal tumour growth...

  • Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct. Tsuyuguchi, Toshio; Sakai, Yuji; Sugiyama, Harutoshi; Miyakawa, Kaoru; Ishihara, Takeshi; Ohtsuka, Masayuki; Miyazaki, Masaru; Yokosuka, Osamu // Journal of Hepato -- Biliary -- Pancreatic Sciences;May2010, Vol. 17 Issue 3, p230 

    Background/Purpose: Intraductal papillary mucinous neoplasm of the bile duct (IPMN-B) is considered an uncommon tumor. The purpose of this study was to evaluate the diagnostic utility of endoscopic cholangiography (ERC) with subsequent peroral cholangioscopy (POCS) and/or intraductal...

  • Primary Mucinous Carcinoma. Weber, Paul J.; Hevia, Oscar; Gretzula, Joseph C.; Rabinovitz, Harold C. // Journal of Dermatologic Surgery & Oncology;Feb88, Vol. 14 Issue 2, p170 

    Primary mucinous carcinoma of the skin is a rare entity. It usually presents as a painless nodule, cyst, or ulcer in the head and neck region (especially the eyelid). These tumors have a low metastatic potential but tend to recur locally. Histologically, groups of light- and dark-staining...

  • The role of autophagy in cancer development and response to therapy. Kondo, Yasuko; Kanzawa, Takao; Sawaya, Raymond; Kondo, Seiji // Nature Reviews Cancer;Sep2005, Vol. 5 Issue 9, p726 

    Autophagy is a process in which subcellular membranes undergo dynamic morphological changes that lead to the degradation of cellular proteins and cytoplasmic organelles. This process is an important cellular response to stress or starvation. Many studies have shed light on the importance of...

  • Immunological inhibition of carcinogenesis. Spadaro, Michela; Lanzardo, Stefania; Curcio, Claudia; Forni, Guido; Cavallo, Federica // Cancer Immunology, Immunotherapy;Mar2004, Vol. 53 Issue 3, p204 

    The combination of new information provided by fundamental immunology, along with the refinement of genetic engineering techniques has given scientists the capacity to produce vaccines able to inhibit the growth of most if not every transplantable tumor. However, when faced with already...

  • Role of nitric oxide in tumour progression with special reference to a murine breast cancer model. Jadeski, Lorraine C.; Chakraborty, Chandan; Lala, Peeyush K. // Canadian Journal of Physiology & Pharmacology;Feb2002, Vol. 80 Issue 2, p125 

    Nitric oxide (NO) is a potent bioactive molecule produced in the presence of NO synthase (NOS) enzymes, which mediates numerous physiological functions under constitutive conditions. Sustained overproduction of NO (and NO-reaction products), typically under inductive conditions, can lead to cell...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics